Tecadenoson
- Generic Name
- Tecadenoson
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C14H19N5O5
- CAS Number
- 204512-90-3
- Unique Ingredient Identifier
- GZ1X96601Z
- Background
Tecadenoson is a novel selective A1 adenosine receptor agonist that is currently being evaluated for the conversion of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm. It is being developed by CV Therapeutics, Inc.
- Indication
Investigated for use/treatment in arrhythmia and atrial fibrillation.
- Associated Conditions
- -
- Associated Therapies
- -
Safety Study of Tecadenoson to Treat Atrial Fibrillation
- First Posted Date
- 2008-07-11
- Last Posted Date
- 2014-03-11
- Lead Sponsor
- Gilead Sciences
- Target Recruit Count
- 21
- Registration Number
- NCT00713401
- Locations
- 🇺🇸
CV Therapeutics, Inc., Palo Alto, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath